Definium Therapeutics, Inc. (DFTX)

NASDAQ: DFTX · Real-Time Price · USD

37.60

-0.46 (-1.21%)

At close: Oct 1, 2026, 4:00 PM EDT

37.77

+0.17 (0.45%)

Pre-market: Oct 2, 2026, 4:58 AM EDT

Definium Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-353.79	-183.79	-108.68	-95.73	-56.8	-93.04
Depreciation & Amortization	-	-	-	-0.04	-0.02	0.02
Other Amortization	-	-	0.53	3.3	4.7	2.6
Loss (Gain) From Sale of Investments	-0.17	-1.82	-	-	-	-
Stock-Based Compensation	35.74	21.56	17.67	15.49	13.71	42.72
Other Operating Activities	134.73	23.06	14.69	6.33	-7.95	-
Change in Accounts Payable	2.75	3.34	-2.13	2.03	-2.06	1.28
Change in Other Net Operating Assets	12.79	6.1	-1.22	4.26	-1.73	1.76
Operating Cash Flow	-167.95	-131.56	-79.13	-64.37	-50.14	-45.82
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash Acquisitions	-	-	-	-	-	-0.3
Investment in Securities	-224.35	-151.61	-	-	-	-
Investing Cash Flow	-224.35	-151.61	-	-	-	-0.3

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	-	42	10	15	-	-
Long-Term Debt Repaid	-	-22	-	-	-	-
Net Debt Issued (Repaid)	-	20	10	15	-	-
Issuance of Common Stock	1,077	263.66	259.97	7.69	43.21	98.82
Repurchase of Common Stock	-	-	-0.05	-	-0.41	-
Other Financing Activities	-62.36	-16.39	-16.72	-0.84	16.25	-
Financing Cash Flow	1,014	267.27	253.2	21.85	59.05	98.82

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.02	-0.01	-0.03	0.08	-0.31	0.74
Net Cash Flow	621.88	-15.9	174.04	-42.44	8.6	53.45

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Levered Free Cash Flow	7.61	-57.81	-45.28	-26.39	-15.82	-8.21
Unlevered Free Cash Flow	10.75	-54.39	-43.85	-25.91	-15.82	-7.99

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash Interest Paid	4.27	5.34	2.22	0.53	-	-
Change in Working Capital	15.54	9.44	-3.34	6.28	-3.78	1.88